ACM
Argent Capital Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-145,357
| Closed | -$30M | – | 155 |
|
|
2024
Q2 | $30M | Sell |
145,357
-1,895
| -1% | -$391K | 0.88% | 37 |
|
|
2024
Q1 | $39.9M | Buy |
147,252
+85,300
| +138% | +$23.1M | 1.16% | 32 |
|
|
2023
Q4 | $14.6M | Sell |
61,952
-93,821
| -60% | -$22.2M | 0.48% | 52 |
|
|
2023
Q3 | $30.5M | Sell |
155,773
-12,617
| -7% | -$2.47M | 1.09% | 33 |
|
|
2023
Q2 | $35.4M | Sell |
168,390
-3,779
| -2% | -$795K | 1.15% | 33 |
|
|
2023
Q1 | $34.7M | Buy |
172,169
+1,938
| +1% | +$391K | 1.2% | 35 |
|
|
2022
Q4 | $37.1M | Buy |
170,231
+780
| +0.5% | +$170K | 1.33% | 29 |
|
|
2022
Q3 | $33.3M | Buy |
169,451
+158,627
| +1,466% | +$31.2M | 1.31% | 28 |
|
|
2022
Q2 | $2.32M | Sell |
10,824
-134
| -1% | -$28.7K | 0.09% | 83 |
|
|
2022
Q1 | $3.11M | Buy |
10,958
+110
| +1% | +$31.2K | 0.1% | 74 |
|
|
2021
Q4 | $4.09M | Buy |
10,848
+176
| +2% | +$66.3K | 0.12% | 71 |
|
|
2021
Q3 | $4.4M | Buy |
10,672
+182
| +2% | +$75.1K | 0.14% | 64 |
|
|
2021
Q2 | $3.88M | Buy |
10,490
+570
| +6% | +$211K | 0.12% | 69 |
|
|
2021
Q1 | $2.88M | Buy |
9,920
+36
| +0.4% | +$10.4K | 0.1% | 77 |
|
|
2020
Q4 | $2.47M | Buy |
9,884
+1,092
| +12% | +$273K | 0.09% | 79 |
|
|
2020
Q3 | $1.99M | Buy |
8,792
+911
| +12% | +$206K | 0.08% | 80 |
|
|
2020
Q2 | $1.37M | Buy |
+7,881
| New | +$1.37M | 0.06% | 99 |
|